Precigen reports third quarter 2020 and year-to-date financial results

Germantown, md., nov. 9, 2020 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced third quarter and year-to-date financial results for 2020....

PGEN Ratings Summary

PGEN Quant Ranking